• Health & Medicine

Cancer in kids, teens and young adults – why we're renewing our focus

Cancer deaths in children and young people have dropped by nearly 60 per cent in the past 40 years - read about our new campaign looking accelerate this trend. Cancer deaths in children and young people have dropped by nearly 60 per cent in the past 40 years - read about our new campaign looking accelerate this trend.

22 January 2015

• Health & Medicine

Cancer deaths in youngsters drop by nearly 60 per cent in 40 years

Cancer deaths in children and young people have fallen by 58 per cent in the past 40 years, according to new figures from Cancer Research UK. Cancer deaths in children and young people have fallen by 58 per cent in the past 40 years, according to new figures from Cancer Research UK.

22 January 2015

Bioinvent’s BI-1206 antibody to enter collaborative phase I/II trial funded and conducted by Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research

Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma. Cancer Research UK, Cancer Research Technology and Leukaemia & Lymphoma Research to trial BioInvent's antibody drug for non-Hodgkin lymphoma.

20 January 2015

• Health & Medicine

Cancer ‘the best way to die’? You couldn't be more wrong if you tried

19 January 2015

• Health & Medicine

Improving the gold standard for brain tumours

We explore new research from our scientists testing a modified version of a brain cancer drug that could help overcome resistance to treatment. We explore new research from our scientists testing a modified version of a brain cancer drug that could help overcome resistance to treatment.

16 January 2015

• Health & Medicine

Does oxygen cause lung cancer? I wouldn’t hold your breath

Does living at high altitude prevent lung cancer? Our bloggers explore a new study that sparked headlines claiming oxygen might cause the disease. Does living at high altitude prevent lung cancer? Our bloggers explore a new study that sparked headlines claiming oxygen might cause the disease.

14 January 2015

• Health & Medicine

Revamped drug may overcome resistance in brain tumours

Cancer Research UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults. Cancer Research UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults.

14 January 2015

• Science & Technology

Gene linked to aggressive breast cancer

UK scientists have linked an overactive gene to an aggressive type of breast cancer. UK scientists have linked an overactive gene to an aggressive type of breast cancer.

12 January 2015

• Health & Medicine

The HOPON clinical trial: a patient’s view

In the final post in our series about the HOPON clinical trial, we hear from a patient who recently took part in the research, Gerard Dean. In the final post in our series about the HOPON clinical trial, we hear from a patient who recently took part in the research, Gerard Dean.

9 January 2015

• Health & Medicine

The HOPON clinical trial: the research nurses’ role

In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool. In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool.

8 January 2015

• Health & Medicine

The HOPON clinical trial: the doctor’s perspective

In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012. In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012.

7 January 2015

• Health & Medicine

More than a third of people with abnormal results drop out of bowel cancer screening

Almost 40 per cent of people who have abnormal results from bowel cancer screening tests ignore their next screening invitation two years later. Almost 40 per cent of people who have abnormal results from bowel cancer screening tests ignore their next screening invitation two years later.

7 January 2015